3 Results for "

TOV-112D

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "TOV-112D" in MCE Product Catalog:

Cat. No.: HY-P99925
CAS No.: 1192578-27-0
Synonyms: REGN421

Target:  

Notch

Research Areas:  

Metabolic Disease Cancer

Enoticumab (REGN421, SAR153192) is an IgG1κ antibody targeting human Dll4. DLL4 is a ligand of the Notch signaling pathway and regulates fatty acid uptake through non-transcriptional regulation of macropinocytosis-dependent long-chain fatty acid uptake. Specific in vivo activity of Enoticumab in an ovarian xenograft model. EGN421 (2.5 mg/kg once weekly) resulted in 86% and 83% tumor growth inhibition in mouse subcutaneous TOV-112D or intraperitoneal A2780 human tumor xenograft models, respectively .
loading...
    loading...
Cat. No.: HY-139150
CAS No.: 2088132-99-2
Research Areas:  

Cancer

EZH2-IN-4 is an orally active, potent EZH2 inhibitor with IC50s of 0.923 nM and 2.65 nM against wild type (WT) 5-membered (5-mer) EZH2 and mutant 5-mer EZH2, respectively. EZH2-IN-4 has anti-cancer activity .
loading...
    loading...
Cat. No.: HY-183622
CAS No.: 304896-41-1
Target:  

MDM-2/p53

Research Areas:  

Cancer

UCI-1014 is a mutant p53 (p53 R175H) corrector/reactivator. UCI-1014 restores the wild-type-like DNA-binding activity of p53 R175H, promotes the redistribution of the mutant protein to chromatin, and induces the expression of p53-dependent target genes. UCI-1014 inhibits the proliferation of p53 R175H-mutant cancer cells through an SLC7A11-independent mechanism. UCI-1014 can be used for research related to p53-mutant cancers .
loading...
    loading...